Population health management at Cleveland clinic

Similar documents
Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Enabling Healthcare in Out-Patient Settings and The Patient Centered Medical Home of the Future

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Nierfunctiemeting en follow-up van chronisch nierlijden

Environmental Health Science. Brian S. Schwartz, MD, MS

Improving Evidence-Based Primary Care for Chronic Kidney Disease. Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet)

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE

The Burden Of Diabetes And The Promise Of Biomedical Research

Estimated GFR Based on Creatinine and Cystatin C

Renal Disease in Type 2 Diabetes Mellitus

Organization and Structure of a Peritoneal Dialysis Program: an important ingredient for success

20/03/2013. What is it and how did it disappear? What is it and how did it not disappear?

Dual RFI Response Summary

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Hemodialysis Dose and Adequacy

2015 AAMC Accelerating Health Equity, Advancing through Discovery (AHEAD) Award Request for Proposal and Application

Host Site: County of San Diego, Public Health Services, Health and Human Services Agency

Johns Hopkins HealthCare LLC: Care Management and Care Coordination for Chronic Diseases

High Blood Pressure and Kidney Disease

Diabetic Nephropathy

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Strengthening the HCV Continuum of Care

ADVANCING MEASUREMENT OF PATIENT- CENTERED OUTCOMES AND QUALITY METRICS WITH ELECTRONIC HEALTH RECORDS

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

Natalia Olchanski, MS, Paige Lin, PhD, Aaron Winn, MPP. Center for Evaluation of Value and Risk in Health, Tufts Medical Center.

Chronic Kidney Disease and Diabetes

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

Medicare Advantage Plans: An Overview

Main Effect of Screening for Coronary Artery Disease Using CT

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156

ONC Project Drives Results with High- Value, Consumer- Friendly Data. [Font: Verdana Size 30]

Medicare Basics and Medicare Advantage

Kidney Interagency Coordinating Committee (KICC) Meeting March 2, 2012, Natcher Conference Center. Meeting Participants and Summary

Guideline for Microalbuminuria Screening

Stage 1 measures. The EP/eligible hospital has enabled this functionality

Prediction of Kidney Disease Progression in Patients with Diabetes

Monitoring the Hemodialysis Dose

We were just accredited for 4 years by the ACGME! We will be surveyed again by them in the fall of 2011.

Accessing Data for Clinical Researchers: The Boston Medical Center Clinical Data Warehouse

Chapter 24: Renal Transplantation in the Older Adult

Health Disparities in Multiple Myeloma. Kenneth R. Bridges, M.D. Senior Medical Director Onyx Pharmaceuticals, Inc.

Mississippi Delta Health Collaborative Mississippi State Department of Health 1

Robert Okwemba, BSPHS, Pharm.D Philadelphia College of Pharmacy

AKI in Acute Dialysis Units outside ICU across Finland

Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Ground Zero: 1997

MedStar Family Choice (MFC) Case Management Program. Cyd Campbell, MD, FAAP Medical Director, MFC MCAC June 24, 2015

Real World Data: How It s Used at a Medical Device Company

Appendix: Description of the DIETRON model

Technology Using Electronic Health Records to Improve the

CRITICAL SKILLS FOR OPTIMUM PATIENT CARE: Care Coordination and Health Literacy

OBJECTIVES FACTS AND FIGURES CMS CHRONIC CARE MANAGEMENT 10/20/2015. Another Step Towards Care Coordination

Update in Contrast Induced Nephropathy

ASCO s CancerLinQ aims to rapidly improve the overall quality of cancer care, and is the only major cancer data initiative being developed and led by

Predictive Analytics in Action: Tackling Readmissions

HCCs and Star-Ratings: An IPA s Successful Approach to Revenue Integrity. Nancy Hirschl, CCS Victoria McKemy, MHA James Taylor, MD, CPC

Hemodialysis catheter infection

PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION

EHR OpenNESS: Innovation and Uptake

Demonstration Study of Healthcare Utilization by Obese Patients. Joseph Vasey PhD Director, Epidemiology Quintiles Outcome May 22, 2013

The Power of PopIQ and Big Data. i2i Systems West Coast Regional User Conference September 5, 2014

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources

Albuminuria versus GFR as markers of diabetic CKD progression

A New Paradigm for Large, Simple Trials Based on Electronic Health Records

DELIVERING VALUE THROUGH TECHNOLOGY

4/25/2016. Transplant Journey. Objectives. Reason for Transplantation at Mayo Clinic. Mayo Clinic Model of Care

Using EHRs, HIE, & Data Analytics to Support Accountable Care. Jonathan Shoemaker June 2014

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

HIMSS Davies Enterprise Application --- COVER PAGE ---

A Comparison of Hemorrhagic and Ischemic Strokes among Blacks and Whites:

We have made the following changes to the Critical Illness events covered under our group critical illness policy.

2012 Georgia Diabetes Burden Report: An Overview

Transcription:

Population health management at Cleveland clinic Sankar D Navaneethan, MD, MS, MPH Using Health Information Technology to Identify and Manage CKD Populations Oct 22-23 2015

Objectives Development of an EHR based CKD registry at Cleveland Clinic Health System Transformation of registry data to knowledge Barriers in development and maintenance

Cleveland Clinic Health System Cleveland Clinic Main Hospital, 8 Community Hospitals &15 Community-based Health Centers Serves >1.5 million people with 75% of patients coming from the seven counties adjacent to Cleveland, Ohio EHR- EPIC (since 2002): routinely used for scheduling, order entry, documentation of progress notes, result review, medication management and provider-to-provider and provider-patient communication.

Cleveland Clinic Health System CKD Registry CLINICAL J. Nally, MD S. Navaneethan, MD S. Jolly, MD J. Simon, MD J. Hyland, CNP BIOSTATISTICS J. Schold, PhD J. Sharp S. Arrigain V. Konig X. Liu E-RESEARCH A. Jain, MD S. Welf, BS Navaneethan SD et al. Clin J Am Soc Nephrol 6: 40 49, 2011

Selection of patients Patients with 2 outpatient serum creatinine values n=292,372 Patients with 2 serum creatinine values at least 90 days apart n=255,409 Patients with 2 serum creatinine values <90 days apart (n=36,963)) Patients with egfr >60 (n=202,010) Patients identified using ICD-9 codes only (n=3,877) Patients with 2 egfr <60 >90 days apart n=53,399 Final Cohort n= 57,276 Updated every 3 months and now has >95,000 patients

Validation of the reliability of EHR data EHR validation - performed in two stages by two investigators Twenty randomly selected EHR generated charts were reviewed to assess whether the ICD-9 codes related to various kidney diseases and comorbid conditions are appropriate 20 random charts were reviewed to exclude the presence of a specific comorbidity that may have been falsely claimed to be present Navaneethan SD et al. Clin J Am Soc Nephrol 6: 40 49, 2011

Our Current Structure USRDS data Social security death index Ohio State death files Cleveland Clinic electronic data warehouse CKD Registry Analytical Files for outcomes research EHRs-based and Identification of participants for other clinical trials Institutional quality improvement projects

Transforming registry data into knowledge Research: Data for health outcomes research, resource for young trainees and to help with recruitment for clinical trials Patient care: Empowering patients using MyChartpersonal health record Providers: Feedback based on various quality metrics/ processes of care measures

Outcomes research projects Associations of vitamin D, serum testosterone, alkaline phosphatase and bicarbonate with mortality in CKD Associations of metabolic syndrome and ESRD/death in CKD Significance of CKD in pulmonary arterial hypertension Role of Implantable cardioverter defibrillator in CKD Utility of Renal resistive index in CKD Cause-specific deaths in CKD Collaborative projects with DECIDE/CKD-PC groups Navaneethan SD AJKD 2011, Navaneethan SD, NDT 2012, Taliercio JJ AJKD 2013, Navaneethan SD CJASN 2013, Jolly AJN 2014, Toledo C Hypertension 2015, Navaneethan SD JASN 2015, Navaneethan SD KI 2015

CKD specific enhanced personal health record (PHR) NIDDK R34 grant to improve outcomes for CKD patients through clinical translational (T2) research 2 x 2 factorial design clinical trial

Randomized Controlled Trial- Navigating the Challenges of CKD Inclusion criteria Age 18-79 years English speaking egfr 15-45 ml/min Patients residing in North East Ohio with CCF PCP Computer Access Exclusion criteria Mentally incompetent Cancer Terminal illness Patients on dialysis and had renal transplant Developed an electronic health record (EHR)-based enhanced personal health record (PHR) that will use electronic communication to disseminate CKD stage-specific goals of care and CKD education to improve outcomes for CKD Stage 3b/4 patients

Registry aids recruitment efforts Patients who meets the specific inclusion/exclusion criteria for clinical trials and prospective studies are identified CRIC, Navigator study, diabetic nephropathy trials Option to provide the study coordinator with their scheduled visits to their provider Saves resources and coordinator time

Challenges Implementation Maintenance EMR based clinical trial

Challenges- Implementation Intent of developing an EMR based registry Role of funding and engaged team members Identifying and organizing the team Priorities for team members/competing clinical needs of the health IT team Speaking the same language

Challenges- Implementation Data dictionary Definitions/Rules are not available for everything that you might ask for Data collection - What to include and what not to

Challenges- Implementation Hospitalization data differences in coding of various hospitals Red blood cell transfusion data- differences in timing of documentation Lack of comprehensive medication details until e-prescription was implemented

Challenges- Maintenance Sustenance- support for the team members Legal team to understand the data sharing needs for collaborative research Loss of SSDI data linkage a new opportunity to think outside the box? Structural changes within the health care system eresearch reassigned to Business Intelligence

Challenges - Maintenance Registry refinements- revisitng rules e.g., internal medicine physicians-residents change over time Need for validation of any new variable being added to the registry Several procedural data: Renal US, ICD and ECHO data- Need for expertise in natural language processing Quality assurance- Changes at the electronic data warehouse

Challenges with EMR based clinical trial Building an enhanced personalized health record within EMR Adding an encounter for patient navigators Focus on MyChart for all across system

Summary EHR based registry development - feasible with the assistance of multi-disciplinary team EHR based registries offer assistance for - outcomes research, recruitment for clinical trials and QI projects Efforts are needed to accommodate changes in health care system, institutional policies and multiple other changes that could impact on the sustenance of such institution-based registries

Acknowledgements Stacey Jolly, MD Jesse D. Schold, PhD Susana Arrigain Victoria Konig Anil Jain MD John Sharp, Joseph V. Nally, MD And the MyChart and other CKD Registry Team members Funding: NIH/NIDDK R34 DK094112, Rosenberg foundation and Unrestricted educational grant from Amgen to the department of Nephrology and Hypertension, Cleveland Clinic Foundation Outcomes data: Ohio Department of Health & USRDS